SAGE

Sage Therapeutics
SAGE

Overview Fund Activity
Delisted

SAGE was delisted on the 30th of July, 2025.

Back to rankings

73 hedge funds and large institutions have $735M invested in Sage Therapeutics in 2014 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 26 increasing their positions, 10 reducing their positions, and 6 closing their positions.

Holders
73
Holders Change
+21
Holders Change %
+40.38%
% of All Funds
1.95%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.08%
New
28
Increased
26
Reduced
10
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BFA
1
BlackRock Fund Advisors
California
$16.9M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$8.15M
3
Stifel Financial
3
Stifel Financial
Missouri
$5.73M
4
JPMorgan Chase & Co
4
JPMorgan Chase & Co
New York
$6.52M
5
Lord, Abbett & Co
5
Lord, Abbett & Co
New Jersey
$3.96M

Top Sellers

1
DM
1
Deerfield Management
New York
$9.61M
2
PA
2
Perceptive Advisors
New York
$2.58M
3
O
3
OrbiMed
New York
$15.1M
4
Millennium Management
4
Millennium Management
New York
$0
5
Alyeska Investment Group
5
Alyeska Investment Group
Illinois
$1.74M
Name Market Value Shares Shares
Change 		Shares
Change %
FSA
76
Franklin Street Advisors
North Carolina
– – -7,650 Closed
CSS
77
Cubist Systematic Strategies
Connecticut
– – -6,895 Closed
TRCT
78
Tower Research Capital (TRC)
New York
– – -252 Closed
KTC
79
Kistler-Tiffany Companies
Pennsylvania
$0 4 – –
1 2 3
4